Leigh Anna Samp, PA-C

Leigh Samp practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Leigh Samp's NPI, 1285645754, was assigned on August 10, 2006. Leigh Samp holds Texas license PA03835.

Leigh Samp's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Leigh Samp's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dmand AI tracks the electronic health record (EHR) system at each site where Leigh Samp practices. Vendor and product names are available with a free account.

Physician assistant is Leigh Samp's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Leigh Samp is licensed in Texas.

CMS counts 13 Medicare patients who saw Leigh Samp in 2024. The largest group is under 65, with 0 patients. 75% of them have high cholesterol. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Leigh Samp's median patient age at 71, with 52% women.

In 2024, Leigh Samp wrote 178 Medicare Part D claims for 47 patients. 51% of them were for generic drugs. CMS names the drug for 122 of them, across 4 drugs with 11 or more claims each, at $139,905 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Leigh Samp for performance year 2024, reported as part of a group. Leigh Samp accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Leigh Samp as offering telehealth.